Joseph Zack joins Metabolon
This article was originally published in Clinica
Metabolomics biomarker company Metabolon has appointed Joseph Zack senior vice-president of diagnostics. Mr Zack has over 30 years of experience in the biopharmaceutical and diagnostics industry, and was previously vice-president of marketing and sales for Orasure Technologies, where he expanded the firm's diagnostic and device business. He has also worked for OraPharma, Advanced Tissue Sciences and Ciba-Geigy Pharmaceuticals (now Novartis). Metabolon has a patented biochemical platform which analyses biological samples to discover markers and pathways associated with diseases and drug action. The Research Triangle Park, North Carolina company is using this metabolomics-driven approach to develop diagnostics for diabetes, prostate cancer and amyotrophic lateral sclerosis.